Microbot Medical (MBOT) Change in Accured Expenses (2010 - 2026)

Microbot Medical's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at $384000.0 for Q1 2026.

• Quarterly Change in Accured Expenses rose 162.24% year-over-year to $384000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 136.71% YoY) and the FY2025 annual result came in at $495000.0, down 43.3% from the prior year.
• Change in Accured Expenses was $384000.0 for Q1 2026 at Microbot Medical, down from $506000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $1.0 million in Q4 2024 and bottomed at -$900000.0 in Q1 2023.
• A 5-year average of $48705.9 and a median of $55000.0 in 2023 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses slumped 1920.0% — and 2025, when it soared 6545.45%.
• Microbot Medical's Change in Accured Expenses stood at $416000.0 in 2022, then tumbled by 86.78% to $55000.0 in 2023, then surged by 1807.27% to $1.0 million in 2024, then tumbled by 51.76% to $506000.0 in 2025, then retreated by 24.11% to $384000.0 in 2026.
• Business Quant data shows MBOT's Change in Accured Expenses at $384000.0 in Q1 2026, $506000.0 in Q4 2025, and -$103000.0 in Q3 2025.